— Know what they know.
Not Investment Advice

ENZC OTC

Enzolytics Inc.
1W: -20.0% 1M: -33.3% 3M: -55.6% YTD: +33.3% 1Y: +100.0% 3Y: -99.0% 5Y: -99.7%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±46.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 44 · $1.9M mcap · 4.74B float · 0.144% daily turnover · Short 20% of daily vol

Balance Sheet Trends

Total Assets
$202M -44.2% ▼
5Y CAGR: +104.8%
Total Liabilities
$320M -12.3% ▼
5Y CAGR: +115.1%
Shareholders Equity
-$119M -3228.5% ▼
Cash & Investments
$200M -44.4% ▼
5Y CAGR: +891.1%
Total Debt
$996K +0.0% ▲
5Y CAGR: +7.5%
Net Debt
$996K +1.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$560K$2M$554K$15K$0
Short-Term Investments$0$0$0$360M$200M
Cash & ST Investments$560K$2M$554K$360M$200M
Net Receivables$0$0$0$0$5K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$560K$2M$554K$360M$200M
Property, Plant & Equip.$5K$151K$128K$106K$84K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$19M$800K$2M$2M$2M
Other Non-Current Assets-$19M$6K$6K$6K$6K
Total Non-Current Assets$8K$956K$2M$2M$2M
Total Assets$568K$3M$2M$362M$202M
— Liabilities —
Accounts Payable$223K$254K$237K$221K$0
Short-Term Debt$1M$1M$1M$996K$996K
Deferred Revenue$0$1M$0$259M$259M
Other Current Liabilities$4M$2M$3M$4M$4M
Total Current Liabilities$5M$5M$5M$364M$319M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$866K$866K$866K$866K$756K
Total Non-Current Liabilities$866K$866K$866K$866K$756K
Total Liabilities$6M$6M$6M$365M$320M
— Equity —
Common Stock$280K$280K$283K$317K$483K
Retained Earnings-$30M-$30M-$33M-$35M-$151M
Accumulated OCI$13K$13K$13K$13K$13K
Total Stockholders Equity-$5M-$2M-$3M-$4M-$119M
Total Liabilities & Equity$568K$3M$2M$362M$202M
— Key Metrics —
Total Debt$1M$1M$1M$996K$996K
Net Debt$547K-$931K$625K$982K$996K
Total Investments$19M$800K$2M$362M$202M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms